-
Je něco špatně v tomto záznamu ?
Anterior gradient 2: a novel player in tumor cell biology
V. Brychtova, B. Vojtesek, R. Hrstka
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- lidé MeSH
- nádorová transformace buněk metabolismus MeSH
- nádorové biomarkery metabolismus MeSH
- nádory metabolismus MeSH
- prognóza MeSH
- proteiny fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
AGR2 has evolutionarily conserved roles in development and tissue regeneration and is linked with several human cancers. The exact functions and regulation of AGR2 are poorly understood, but current data identify AGR2 as a clinically relevant factor that modulates the behavior and response of hormone-dependent cancers (breast, prostate) and hormone-independent cancers (colorectal, pancreatic, esophageal and other common cancers). AGR2 protein expression induces metastasis, acts as a p53 tumor suppressor inhibitor and survival factor, participates directly in neoplastic transformation and is involved in drug resistance. Thus, AGR2 is an important tumor biomarker and negative prognostic factor potentially exploitable in clinical practice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027025
- 003
- CZ-PrNML
- 005
- 20160502065929.0
- 007
- ta
- 008
- 120816s2011 ie f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.canlet.2010.12.023 $2 doi
- 035 __
- $a (PubMed)21371820
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Brychtová, Veronika $7 xx0228678 $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 245 10
- $a Anterior gradient 2: a novel player in tumor cell biology / $c V. Brychtova, B. Vojtesek, R. Hrstka
- 520 9_
- $a AGR2 has evolutionarily conserved roles in development and tissue regeneration and is linked with several human cancers. The exact functions and regulation of AGR2 are poorly understood, but current data identify AGR2 as a clinically relevant factor that modulates the behavior and response of hormone-dependent cancers (breast, prostate) and hormone-independent cancers (colorectal, pancreatic, esophageal and other common cancers). AGR2 protein expression induces metastasis, acts as a p53 tumor suppressor inhibitor and survival factor, participates directly in neoplastic transformation and is involved in drug resistance. Thus, AGR2 is an important tumor biomarker and negative prognostic factor potentially exploitable in clinical practice.
- 650 _2
- $a nádorová transformace buněk $x metabolismus $7 D002471
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x metabolismus $7 D009369
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a proteiny $x fyziologie $7 D011506
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Vojtěšek, Bořivoj, $d 1960- $7 xx0001694 $u Department of Immunology and Molecular Biology, Research Institute of Clinical and Experimental Oncology, Brno., Czechoslovakia
- 700 1_
- $a Hrstka, Roman $7 xx0077297 $u Masaryk Memorial Cancer Institute, Regional Centre for Applied Molecular Oncology, Zluty kopec 7, 656 53 Brno, Czech Republic
- 773 0_
- $w MED00001044 $t Cancer letters $x 1872-7980 $g Roč. 304, č. 1 (2011), s. 1-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21371820 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160502070032 $b ABA008
- 999 __
- $a ok $b bmc $g 949067 $s 784371
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 304 $c 1 $d 1-7 $e 20110302 $i 1872-7980 $m Cancer letters $n Cancer Lett $x MED00001044
- LZP __
- $b NLK122 $a Pubmed-20120816/11/02
